pharma · Recurrent Respiratory Tract Infections · Actinic Keratosis on the Face or Scalp
ALMIRALL S.P.A
Almirall, S.A.
ALMIRALL S.P.A is a pharma organization headquartered in Barcelona, IT. Primary therapeutic focus areas include Recurrent Respiratory Tract Infections, Actinic Keratosis on the Face or Scalp, Alopecia areata, Actinic Ker
VIA MESSINA 38, MILANO, Mi 20154, IT, Barcelona HQ
2 Employees
NMPA registrant Type
Company details
- Status
- Public
- HQ
- VIA MESSINA 38, MILANO, Mi 20154, IT, Barcelona
- Employees
- 2
- Programs
- 11
- Drugs
- 20
- Patents
- 308
Placebo for LAD603, LAD603
Phase 2 · small molecule · Alopecia areata
Placebo for LAD603, LAD603 for Alopecia areata is a Phase 2 program (small_molecule) at Almirall, S.A. with 1 ClinicalTrials.gov record(s).
Internal code M-00223-20
Full intelligence profile for this program is being prepared.
At a glance
- Sponsor
- Almirall, S.A.
- Phase
- Phase 2
- Modality
- small_molecule
- Indication
- Alopecia areata
- Status
- active
- Trials
- 1